High affinity is insufficient for strong B cell activation by HIV broadly neutralising antibodies
Abstract HIV broadly neutralizing antibodies (bnAbs) have been widely studied, and inducing a robust broadly neutralizing response remains a goal for many human vaccine studies. Much research focusses on creating higher affinity antigens to target bnAb precursors, however this ignores the role of no...
Gardado en:
| Principais autores: | , , , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Nature Portfolio
2026-05-01
|
| Series: | npj Vaccines |
| Acceso en liña: | https://doi.org/10.1038/s41541-026-01468-y |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|